Exhibit 99.2
MSCP HOLDINGS, INC. & AFFILIATES
CONSOLIDATING BALANCE SHEET
January 31, 2003
[in thousands]
MEDICALOGIC/ MSCP MEDICALOGIC
MEDSCAPE, HOLDINGS, ENTERPRISES, INC.
INC. INC.
Assets
Current assets:
Cash and cash equivalents ...................... $ (30) $ --- $ ---
Short-term investments ......................... 43,614 --- ---
Accounts receivable, net ....................... --- --- ---
Prepaid and other current assets ............... 1,025 --- ---
Total current assets ........................ 44,609 --- ---
Property and equipment, net ....................... --- --- ---
Goodwill and intangible assets, net ............... --- --- ---
Long-term investment and other assets, net ........ 320 320 ---
Total assets ...................................... $ 44,929 $ 320 $ ---
MEDICALOGIC MEDICALOGIC MEDICALOGIC ELIMINATING
PENNSLYVANIA, OF TEXAS, TEXAS, LP ENTRIES CONSOLIDATED
Assets LLC INC.
Current assets:
Cash and cash equivalents ...................... $ --- $ --- $ --- $ --- $ (30)
Short-term investments ......................... --- --- --- --- 43,614
Accounts receivable, net ....................... --- --- --- ---
Prepaid and other current assets ............... --- --- --- --- 1,025
Total current assets ........................ --- --- --- --- 44,609
Property and equipment, net ....................... --- --- --- --- ---
Goodwill and intangible assets, net ............... --- --- --- --- ---
Long-term investment and other assets, net ........ --- --- --- (320) 320
Total assets ...................................... $ --- $ --- $ --- $ (320) $ 44,929
Liabilities and shareholders' equity MEDICALOGIC MSCP MEDICALOGICE
MEDSCAPE, INC. HOLDINGS, INC. ENTERPRISES, INC.
Current liabilities:
Accounts payable ............................... $ 236 $ --- $ ---
Accrued and other liabilities .................. 2,787 --- ---
Deferred revenue ............................... --- --- ---
Long-term liabilities, current portion ......... --- --- ---
Other current liabilities ........................ --- --- ---
Total current liabilities ................... 3,023 --- ---
Long-term liabilities, net of current portion ..... --- --- ---
Long-term deferred revenue, net of current portion --- --- ---
Other long-term liabilities ....................... --- --- ---
Total liabilities ........................... 3,023 --- ---
Convertible redeemable series A preferred stock ... 19,626 --- ---
Shareholders' equity:
Common stock ................................... 1,255,103 728,916 ---
Common stock notes receivable, net ............. (439) --- ---
Warrants ....................................... 52,077 --- ---
Deferred stock compensation .................... --- --- ---
Accumulated deficit ............................ (1,284,461) (728,596) ---
Total shareholders' equity .................. 22,280 320 ---
Total liabilities and shareholder's equity $ 44,929 $ 320 $ ---
Liabilities and shareholders' equity MEDICALOGIC MEDICALOGIC MEDICALOGIC ELIMINATING
PENNSYLVANIA, OF TEXAS, TEXAS, LP ENTRIES CONSOLIDATED
LLC INC.
Current liabilities:
Accounts payable ............................... $ --- $ --- $ --- $ --- $ 236
Accrued and other liabilities .................. --- --- --- --- 2,787
Deferred revenue ............................... --- --- --- --- ---
Long-term liabilities, current portion ......... --- --- --- --- ---
Other current liabilities ........................ --- --- --- --- ---
Total current liabilities ................... --- --- --- --- 3,023
Long-term liabilities, net of current portion ..... --- --- --- --- ---
Long-term deferred revenue, net of current portion --- --- --- --- ---
Other long-term liabilities ....................... --- --- --- --- ---
Total liabilities ........................... --- --- --- --- 3,023
Convertible redeemable series A preferred stock ... --- --- --- --- 19,626
Shareholders' equity:
Common stock ................................... --- --- --- (728,916) 1,255,103
Common stock notes receivable, net ............. --- --- --- --- (439)
Warrants ....................................... --- --- --- --- 52,077
Deferred stock compensation .................... --- --- --- --- ---
Accumulated deficit ............................ --- --- --- 728,596 (1,284,461)
Total shareholders' equity .................. --- --- --- (320) 22,280
Total liabilities and shareholder's equity $ --- $ --- $ --- $ (320) $ 44,929
--- --- --- ---
The accompanying unaudited special purpose financial information was
prepared for the purpose of complying with the reporting requirements of the
Office of the United States Trustee and are not intended to be a presentation in
conformity with accounting principles generally accepted in the United States.